M. Ersoy, “Can Immature Granulocytes Guide Chemotherapy Decisions in Later Lines of Therapy for HER2-Negative Breast Cancer?”, Eur Res J, vol. 12, no. 1, pp. 86–96, Jan. 2026, doi: 10.18621/eurj.1764519.